...
首页> 外文期刊>Journal of biomedical materials research, Part A >Influence of cyclodextrins on the proliferation of HaCaT keratinocytes in vitro
【24h】

Influence of cyclodextrins on the proliferation of HaCaT keratinocytes in vitro

机译:环糊精对HaCaT角质形成细胞体外增殖的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Safety and efficacy of pharmaceutical agents can be greatly improved by encapsulation within, or covalent attachment to, a biomaterial carrier. Drug delivery systems must deliver the necessary amount of drug to the targeted site for a necessary period of time, both efficiently and precisely. Various kinds of high-performance biomaterials are being constantly developed for this purpose. Cyclodextrins are potential candidates for such a role, because of their ability to alter physical, chemical, and biological properties of guest molecules through the formation of inclusion complexes. The alpha-, beta-, and gamma-cyclodextrins are widely used natural cyclodextrins, consisting of six, seven, and eight D-glucopyranose residues, respectively, linked by -1,4 glycosidic bonds into a macro cycle. Each cyclodextrin has its own ability to form inclusion complexes with specific guests, an ability, which depends on a proper fit of the guest molecule into the hydro-phobic cyclodextrin cavity. The most common pharmaceutical application of cyclodextrins is to enhance the solubility, stability, and bioavailability of drug molecules. Such kinds of ligand-receptor complexes can be used for different applications, e.g., for a transdermal therapeutic system (TTS) or in biofunctional textiles. The aim of this study was the investigation of the influence of the different cyclodextrins on the cell proliferation using HaCaT keratinocytes as an in vitro test system. Moreover, the study was performed to find harmless and nontoxic cyclodextrin concentrations for dermal applications. By means of different independent in vitro tests could be confirmed that alpha-, beta-, and gamma-cyclodextrins in concentrations up to 0.1 percent (w/v) do not show any antiproliferative influence on HaCaT keratinocytes. Sometimes even proliferative effects could be found. However, all used cyclodextrins (besides gamma-cyclodextrin and its derivatives) in concentrations of 0.5 and 1 percent (w/v), respectively, exert a cytotoxic influence on the proliferation of HaCaT keratinocytes. On the basis of these findings, the following rank order of cyclodextrins regarding their cytotoxicity was proposed: M-beta-CD > beta-CD > HP-beta-CD > alpha-CD > (gamma-CD). It could be confirmed that beta-CD and M-beta-CD trigger the activity of the effectors caspases -3 and -7. A significant increase of LDH release could be found for beta-CD and methyl-beta-CD in concentrations of 0.5 and 1 percent (w/v). The calculated cytotoxicity amounted 45 and 79 percent, respectively. The measurements of the interleukins IL-6 and IL-8 confirmed the findings of the proliferation assays as well as the LDH measurements. These findings may provide further rationale to the use of CDs in topical formulations for dermal and transdermal drug delivery or as raw material to functionalize textiles for medical applications.
机译:通过封装在生物材料载体中或共价附于生物材料载体,可以大大提高药剂的安全性和功效。药物输送系统必须在必要的时间内有效且精确地将必要量的药物输送到目标部位。为此目的,正在不断开发各种高性能的生物材料。环糊精是这种作用的潜在候选者,因为它们能够通过形成包合物来改变客体分子的物理,化学和生物学特性。 α-,β-和γ-环糊精是广泛使用的天然环糊精,分别由六个,七个和八个D-吡喃葡萄糖残基组成,它们通过-1,4个糖苷键连接成一个大环。每种环糊精都有与特定客体形成包合物的能力,这种能力取决于客体分子对疏水性环糊精腔的适当配合。环糊精最常见的药物应用是增强药物分子的溶解性,稳定性和生物利用度。这类配体-受体复合物可用于不同的应用,例如用于透皮治疗系统(TTS)或生物功能纺织品。这项研究的目的是使用HaCaT角质形成细胞作为体外测试系统,研究不同环糊精对细胞增殖的影响。此外,进行该研究以发现用于皮肤的无害且无毒的环糊精浓度。通过不同的独立体外试验,可以确认浓度高达0.1%(w / v)的α-,β-和γ-环糊精对HaCaT角质形成细胞没有任何抗增殖作用。有时甚至可以发现增生作用。但是,所有使用过的环糊精(除γ-环糊精及其衍生物外)的浓度分别为0.5%和1%(w / v),对HaCaT角质形成细胞的增殖具有细胞毒性作用。基于这些发现,提出了环糊精关于其细胞毒性的以下排序:M-β-CD>β-CD>HP-β-CD>α-CD>(γ-CD)。可以证实,β-CD和M-β-CD触发效应胱天蛋白酶-3和-7的活性。对于β-CD和甲基-β-CD,LDH的释放量显着增加,浓度为0.5%和1%(w / v)。计算的细胞毒性分别为45%和79%。白介素IL-6和IL-8的测量结果证实了增殖测定的结果以及LDH的测量结果。这些发现可能为在皮肤和透皮药物递送的局部制剂中使用CD或作为使医学用途的纺织品功能化的原料提供进一步的理由。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号